SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go?
PFE 25.82+2.3%9:46 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BDR who wrote (4227)7/10/1998 9:26:00 PM
From: Anthony Wong  Read Replies (2) of 9523
 
Summary of analyst ratings issued on PFE today:

''buy'' by analyst Christina Heuer at Salomon Smith Barney, target price $155.00

''strong buy'' by analyst David F. Saks at Gruntal & Co., target price $148.00

''buy'' by analyst Cynthia A. Beach at Gerard Klauer Mattison, target price $140.00

''buy'' by analyst Jerome R. Brimeyer at Warburg Dillon Read Inc target price $135.00

''buy'' by analyst Leonard S. Yaffe Md at NationsBanc Montgomery Sec., target price $132.00

''buy'' by analyst Carl J. Seiden at J.P. Morgan Securities, target price $131.00

near-term and long-term ''buy'' by analyst Steven C. Tighe at Merrill Lynch, no target price provided

''buy'' by analyst Kenneth R. Nover at A.G. Edwards, no target price provided

''attractive'' by analyst Jeffrey Chaffkin at PaineWebber Inc. target price $130.00

''outperform'' by analyst Jami Rubin at Schroder & Co. , target price $130.00

''outperform'' by analyst Paul A. Brooke at Morgan Stanley Dean Witter., target price $120.00

Note:
1) Target price - for 12 months, per share basis.
2) All are reiterations of old ratings, no upgrades or downgrrades.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext